We are live on
!
Find out more
TRIM
Thompson Rubinstein Investment Management Portfolio holdings
AUM
$311M
1-Year Est. Return
11.71%
This Fund
S&P 500
This Quarter
Est. Return
-3.2%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.77%
5 Year Est. Return
+48.6%
10 Year Est. Return
–
AUM
$294M
AUM Growth
-$9.85M
(-3.2%)
Cap. Flow
+$1.77M
Cap. Flow
% of AUM
0.6%
Top 10 Holdings %
Top 10 Hldgs %
39.32%
Holding
79
New
1
Increased
20
Reduced
12
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kroger
KR
|
+$2.02M |
| 2 |
CELG
Celgene Corp
CELG
|
+$768K |
| 3 |
Intel
INTC
|
+$486K |
| 4 |
Biogen
BIIB
|
+$153K |
| 5 |
GE Aerospace
GE
|
+$106K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$892K |
| 2 |
PPG Industries
PPG
|
+$684K |
| 3 |
ING
ING
|
+$376K |
| 4 |
Flowserve
FLS
|
+$78.4K |
| 5 |
Woodward
WWD
|
+$60.2K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.28% |
| 2 | Industrials | 22.33% |
| 3 | Technology | 18.33% |
| 4 | Consumer Staples | 8.63% |
| 5 | Energy | 8.56% |
Similar funds
CFS
SVWA
SAS
LYV
TAT
NAP
OAMU
TCM
Thompson Rubinstein Investment Management's Q1 2018 Portfolio in Review
As of Q1 2018, Thompson Rubinstein Investment Management held 79 positions worth $294M, down 3.2% from $304M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 3.8%. Thompson Rubinstein Investment Management opened 1 new position and exited 2, leaving the 79-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Industrials and Technology.
- Thompson Rubinstein Investment Management's largest Q1 2018 buy was Kroger: 74,507 shares worth $1.78M.
- Thompson Rubinstein Investment Management added most to Celgene Corp in Q1 2018, an estimated $768K increase.
- Thompson Rubinstein Investment Management's biggest Q1 2018 reduction was PPG Industries, cutting an estimated $684K.
- Thompson Rubinstein Investment Management fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $892K.
- Thompson Rubinstein Investment Management's ten largest holdings make up 39% of its $294M portfolio in Q1 2018.
- Thompson Rubinstein Investment Management opened 1 new position and closed 2 in Q1 2018.
- Thompson Rubinstein Investment Management's portfolio value fell 3.2% quarter-over-quarter to $294M.
Based on Thompson Rubinstein Investment Management's 13F filing for Q1 2018, filed 6 Apr 2018.